Clinical updates, including trial initiations, enrollment status and data readouts and publications.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief.

New hires and promotions in the med-tech industry.

Med-tech firms raising money in public or private financings.

Aztherapies Inc., of Boston, said it closed a $26.3 million series C preferred equity financing co-led by Spinnaker Capital and Cosine, with participation from new and existing investors, including Drads Capital, IBS Capital and Wexford Capital.

To study pancreatic, breast and small-cell lung cancers, Sunshine Biopharma Inc., of Montreal, has initiated studies of Adva-27a, designed to shrink tumors, in xenograft mice with tumors. Adva-27a is a GEM-difluorinated C-glycoside derivative of podophyllotoxin and is designed to inhibit the enzyme topoisomerase II.